A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors

Post time 2024-3-6 17:26:15

journal：Cancer Immunology Research

Authors：Lisa A. King; Elisa C. Toffoli; Myrthe Veth; Victoria Iglesias-Guimarais; Manon C. Slot; Derk Amsen; Rieneke van de Ven; Sarah Derks; Marieke F. Fransen; Jurriaan B. Tuynman; Thilo Riedl; Rob C. Roovers; Anton E.P. Adang; Jurjen M. Ruben; Paul W.H.I. Parren; Tanja D. de Gruijl; Hans J. van der Vliet

Published date：2023-9-1

DOI：10.1158/2326-6066.cir-23-0189

PDF link：https://aacrjournals.org/canceri ... 836/cir-23-0189.pdf

Article link：http://dx.doi.org/10.1158/2326-6066.cir-23-0189

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 2024-3-6 17:26:16

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AACR] A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors Copy